0B68 Iozzo, Renato V. - Thomas Jefferson University - Thomas Jefferson University

Renato V. Iozzo, MD

Contact Dr. Iozzo

1020 Locust Street
Suite 336 Alumni Hall
Philadelphia, PA 19107

(215) 503-2208
(215) 923-7969 fax

Most Recent Peer-reviewed Publications

  1. Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
  2. Sortilin regulates progranulin action in castration-Resistant prostate cancer cells
  3. Endorepellin evokes autophagy in endothelial cells
  4. Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and mitostatin
  5. Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells
  6. The injury response of aged tendons in the absence of biglycan and decorin
  7. FOXD1 promotes nephron progenitor differentiation by repressing decorin in the embryonic kidney
  8. Reprint of: Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells
  9. The tendon injury response is influenced by decorin and biglycan
  10. Ligand-mediated endocytosis and trafficking of the insulin-like growth factor receptor I and insulin receptor modulate receptor function
  11. The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer
  12. Decorin deficiency promotes hepatic carcinogenesis
  13. Biglycan and decorin differentially regulate signaling in the fetal membranes
  14. Instructive roles of extracellular matrix on autophagy
  15. The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling
  16. Osteoblastic cell secretome: A novel role for progranulin during risedronate treatment
  17. A decorin-deficient matrix affects skin chondroitin/dermatan sulfate levels and keratinocyte function
  18. Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology
  19. Cell-matrix interactions: Focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer
  20. Soluble biglycan as a biomarker of inflammatory renal diseases